All Type of News
Healthcare providers urged to renew license
The Ministry of Health and Welfare said Tuesday that all medical staff should renew their license every three years, along with completion of refresher courses.
The medical personnel includes Western doctors, Orien...
541,000 elderly people struggling with dementia in 2012
About 541,000 people aged over 65, or 9.18 percent of all senior citizens, were estimated to have received treatment for Alzheimer’s disease last year, up from 8.4 percent in 2008 and 8.74 percent in 2010, according t...
Jeil wins lawsuit over patent troll
Jeil Pharmaceutical scored a victory in a patent dispute of Baraclude (entecavir) against BMS Korea.
The Korean company said Monday that the Korean Intellectual Property Tribunal had ruled in favor of Jeil last wee...
Alcon, Ciba Vision wind up consolidation procedures in Korea
The legal consolidation procedures between Alcon and Ciba Vision was completed here as of May 1, both company officials said.
Following completion of the merger, Alcon will become the new eye care division of Novar...
MFDS changes safety information on statin drugs
The Ministry of Food and Drug Safety (MFDS) are adding warnings to the labels of nine statins (484 products from 122 firms), cholesterol lowering drugs, to say they may raise a variety of adverse drug reactions.
Th...
Pfizer Korea rolls out Viagra L in small packet
Pfizer Korea said Monday it has launched a small packet of film-type Vigara L (sildenafil citrate 50 mg, 100 mg) to maintain its leading status in the local impotence-treating market.
Packaging in boxes of 4 tablet...
Bang to lead Regulatory Affairs Division of MSD Korea
MSD Korea said Monday it has appointed as its new regulatory affairs director, Bang He-ryon, a renowned expert in drug license business.
Bang will take charge of the Seoul-based pharmaceutical firm over a variety ...
Hanmi receives tentative FDA approval for incrementally modified Nexium capsules
Hanmi Pharmaceutical said Sunday that the U.S. Food and Drug Administration has recently granted tentative approval to the company's New Drug Application (NDA) for esomeprazole strontium delayed-release capsules.
...
Promising chemotherapy candidate for advanced ovarian cancer may be commercialized, Quest Pharma say
Quest PharmaTech Inc., Canada based pharmaceutical company, is expected to commercialize Oregovomab, a promising chemotherapy candidate for advanced ovarian cancer, according to Quest Pharma.
Oregovomab, a high aff...
Yuhan, Hanmi fare well in first quarter
Yuhan Corporation and Hanmi Pharmaceutical saw their first-quarter sales jump from a year before, while Dong-A Socio Holdings, Green Cross Corporation and Daewoong Pharmaceutical have still struggled to find their fee...
